Pipeline Analysis Reveals 85+ Drugs in Development for Metastatic Prostate Cancer Treatment
• DelveInsight's comprehensive analysis identifies over 80 pharmaceutical companies actively developing 85+ pipeline drugs for metastatic prostate cancer treatment.
• Novel therapies in development include TAVT-45, a reformulated abiraterone acetate, and Onvansertib, a first-in-class PLK1 inhibitor, demonstrating innovation in treatment approaches.
• Multiple clinical trials are underway, including Phase III studies by major players like Bayer, AstraZeneca, and Novartis, evaluating new treatment combinations and targeted therapies.
Valerio Therapeutics Halts Clinical Trials, Pivots to Early-Stage Drug Development
• Valerio Therapeutics announces immediate discontinuation of all clinical trials, including the VIO-01 trial, amid financial challenges with only three months of cash runway remaining.
• The company will shut down its U.S. operations in Lexington, MA and cease clinical-stage oncology programs to focus exclusively on early-stage drug development platform technologies.
• Strategic restructuring will emphasize development of single chain antibody platform integrated with chemistry capabilities and oligonucleotides expertise for future therapeutic development.
Valerio Therapeutics Expands Antibody Development Capabilities with Emglev Therapeutics Acquisition
• Valerio Therapeutics has acquired Emglev Therapeutics, gaining access to innovative single-domain antibody (sdAb) technology that enables fully human antibody development through in vitro processes.
• The acquisition, executed through Valerio's subsidiary Valour Bio, strengthens their therapeutic pipeline with applications in autoimmune diseases, inflammatory disorders, and cancer treatment modalities.
• Emglev's platform has demonstrated preclinical success with various therapeutic approaches, including CAR-T sdAb, BiTE sdAb, and sdAb-drug conjugates, promising accelerated development with reduced immunogenicity risks.
© Copyright 2025. All Rights Reserved by MedPath